Fitzpatrick Successfully Defends Patents Related To Pozen’s Vimovo® Product
Following a six day trial, on June 26, 2017, Judge Cooper of the District of New Jersey ruled in favor of Fitzpatrick’s client Pozen Inc., upholding the validity of U.S. Patent Nos. 6,926,907 and 8,557,285. The patents covered products having unique formulations utilizing uncoated esomeprazole. The trial team showed that the invention ran contrary to conventional wisdom at the time, which was that esomeprazole required an enteric coating.
Fitzpatrick was part of the trial team assigned with protecting Pozen Inc.’s patents-in-suit. The Fitzpatrick team consisted of Dominick Conde and associate Zachary Garrett.